UTI Small Cap Fund · Regular · Growth
NAV
₹26.6406
as of 29 Sept 2026
Expense Ratio
2.02%
AUM
₹4,890 Cr
Lumpsum returns (CAGR)
- 1Y
- +5.30%
- 3Y
- +11.86%
- 5Y
- +13.16%
- Since Inception
- +3.88%
SIP returns (XIRR)
- 1Y
- +7.46%
- 3Y
- +7.20%
- 5Y
- +12.07%
- Since Inception
- +6.20%
Returns calculated from 06 May 2002 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
What history actually did — last 5 years (Oct 2021 – Sept 2026)
A ₹5,000 monthly SIP for the last 5 years (Oct 2021 – Sept 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹3,94,306 today — ₹2,95,000 invested, 11.9% XIRR.
₹2,95,000
Invested
₹3,94,306
Value today
11.9%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 5 years (Oct 2021 – Sept 2026)
Real NAV backtest
₹1,00,000 invested 5 years ago would be ₹1,84,855 today (13.1% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Oct 2021 would still hold ₹14,54,247.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹3,94,306 in this fund vs ₹4,20,465 in the benchmark — underperformance of ₹26,159.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 5 years (Oct 2021 – Sept 2026) (3 Jun 2024) would be ₹1,20,007 today (1.20×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.53
Sharpe Ratio
+0.05
Alpha
0.51
Beta
0.53
Sortino
15.36%
Std Dev
-18.94%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals & Biotechnology10.77%
- Industrial Products7.68%
- Healthcare Services6.63%
- Banks6.53%
- Chemicals & Petrochemicals5.95%
- Capital Markets5.73%
- Auto Components4.95%
- Finance4.62%
- Consumer Durables4.52%
- Electrical Equipment4.33%
- Commercial Services & Supplies4.31%
- IT - Software3.59%
Each sector links to the mutual funds most exposed to it.
Thinking about UTI Small Cap Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
- 1Navin Fluorine International L2.52%
- 2Karur Vysya Bank Ltd.2.48%
- 3Acutaas Chemicals Limited2.33%
- 4Ujjivan Small Finance Bank Ltd2.21%
- 5Td Power Systems Ltd.1.86%
- 6City Union Bank1.84%
- 7Aster Dm Quality Care Limited1.78%
- 8Marksans Pharma Ltd.1.75%
- 9Affle 3i Limited1.69%
- 10Caplin Point Laboratories Ltd1.67%
What this fund does
UTI Small Cap Fund · Regular · Growth aims to generate long-term capital appreciation by investing in small-cap companies — ranked 251st and below by market capitalisation. Small-cap funds carry wider price swings than large-cap and mid-cap funds.
About This Fund
UTI Small Cap Fund · Regular · Growth is a Small Cap mutual fund offered by UTI Mutual Fund. The fund has been operational for over 25 years. It manages assets worth ₹4,890 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against Nifty Smallcap 250 TRI. The current expense ratio is 2.02%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •Small-cap stocks can swing sharply in both directions — the category is built for money that can stay invested for years
- •SIP investors who can benefit from rupee cost averaging during market fluctuations